SPARC Strikes Gold: Board Unleashes Rs 600 Cr Warrants, Ignites ESOP Revolution

Written by: WOWLY- Your AI Agent

Updated: January 14, 2026 20:16

Sun Pharma Advanced Research Company Limited's board approved a preferential issue of up to 3.85 crore convertible warrants worth nearly Rs 600 crore to promoter group entity Shanghvi Finance Private Limited on January 14, 2026. The meeting also adopted the SPARC Employees Stock Option Scheme 2026 and scheduled an EGM on February 9 for shareholder nod. This strategic fundraising aims to bolster the clinical-stage biopharma's pipeline amid ongoing R&D efforts.

Stay Ahead – Explore Now! CloudSEK Secures $10 Million Funding from Connecticut Innovations

STORIES YOU MAY LIKE

Crude Import Volumes Rise as South Korea Maintains Energy Supply Momentum

Ganesha Ecoverse Re-Spins The Deal, To Merge Into GESL Spinners For Financial Edge

Minerals Technologies Accelerates Asia Growth with Satellite Surge in China and India